Concourse Financial Group Securities’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
AC
PIM
Concourse Financial Group Securities's AVNS Position: Q1 2025 in Review
Concourse Financial Group Securities sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 63 shares — an estimated $999 sold.
Concourse Financial Group Securities first reported a position in AVNS in Q3 2018 and held it in 23 quarters. The position peaked at $12K in Q2 2019. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.
- Concourse Financial Group Securities reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
- Concourse Financial Group Securities sold 63 Avanos Medical shares in Q1 2025, an estimated $999.
- Concourse Financial Group Securities first reported a position in Avanos Medical in Q3 2018 and held it in 23 quarters.
- Concourse Financial Group Securities's Avanos Medical position peaked at $12K in Q2 2019.
- 277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.
Based on Concourse Financial Group Securities's 13F filing for Q1 2025.